Literature DB >> 11793473

Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan.

Miwako Dakeishi1, Takanobu Shioya, Yasuhiko Wada, Tsutomu Shindo, Kousei Otaka, Motomu Manabe, Jun-Ichi Nozaki, Sumiko Inoue, Akio Koizumi.   

Abstract

Hereditary hemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome) is an autosomal dominant disorder characterized by aberrant vascular development. We report here a genetic epidemiologic study in a county, A, in the Akita prefecture (population 1.2 million) located in northern Japan. Nine HHT patients who had been referred to tertiary-care hospitals were located in and near the study county. A total of 137 pedigree members were traced of which 81 were alive and 32 were affected by HHT. Complications associated with cerebral or pulmonary arteriovenous malformations were proven in six out of seven families. Linkage analysis in two large families revealed a weak yet suggestive linkage to the HHT1 locus (encoding endoglin; ENG). Three novel mutations were found in four families, all of which led to a frameshift: a G to C transversion at the splicing donor site of intron 3 (Inv3+1 G>C) in one family, one base pair insertion (A) at nucleotide 828 (exon 7) of the endoglin cDNA in two large families (c.828-829 ins A), and a four base pair deletion (AAAG) beginning with nucleotide 1120 (exon 8) of the endoglin cDNA (c.1120-1123 delAAAG) in one family. The insertion of A in exon 11 (c.1470-1471 insA) mutation found in one family has also been reported in a European family. No endoglin gene mutations were found in two families. The population prevalence of HHT in the county was estimated to be 1:8,000 approximately 1:5,000, roughly comparable with those reported in European and U.S. populations, which is contradictory to the traditional view that HHT is rare among Asians. We recommend that families with HHT be screened for gene mutations in order that high-risk individuals receive early diagnosis and treatment initiation that will substantially alter their clinical course and prognosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793473     DOI: 10.1002/humu.10026

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  79 in total

1.  [Recurring nose bleeds, dyspnea and conspicuous findings in the lung and liver].

Authors:  K Holzapfel; N von Beckerath; E J Rummeny; J Gaa
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

2.  Directional next-generation RNA sequencing and examination of premature termination codon mutations in endoglin/hereditary haemorrhagic telangiectasia.

Authors:  F S Govani; A Giess; I G Mollet; M E Begbie; M D Jones; L Game; C L Shovlin
Journal:  Mol Syndromol       Date:  2013-04-11

3.  Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment.

Authors:  Aditya Bharatha; Marie E Faughnan; Helen Kim; Tony Pourmohamad; Timo Krings; Pinar Bayrak-Toydemir; Ludmila Pawlikowska; Charles E McCulloch; Michael T Lawton; Christopher F Dowd; William L Young; Karel G Terbrugge
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

Review 4.  Embolisation for pulmonary arteriovenous malformation.

Authors:  Charlie C-T Hsu; Gigi Nc Kwan; Hannah Evans-Barns; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2018-01-04

5.  Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years.

Authors:  T Krings; A Ozanne; S M Chng; H Alvarez; G Rodesch; P L Lasjaunias
Journal:  Neuroradiology       Date:  2005-09-01       Impact factor: 2.804

Review 6.  Venous pathologies in paediatric neuroradiology: from foetal to adolescent life.

Authors:  Kshitij Mankad; Asthik Biswas; Maria Camilla Rossi Espagnet; Luke Dixon; Nihaal Reddy; Ai Peng Tan; Ozgur Oztekin; Felice D'Arco; Karuna Shekdar; Prakash Muthusami; Fergus Robertson; Stacy Goergen; Winston Chong
Journal:  Neuroradiology       Date:  2019-11-09       Impact factor: 2.804

7.  Dynamic 4D MR angiography versus multislice CT angiography in the evaluation of vascular hepatic involvement in hereditary haemorrhagic telangiectasia.

Authors:  A Scardapane; A Stabile Ianora; C Sabbà; M Moschetta; P Suppressa; L Castorani; G Angelelli
Journal:  Radiol Med       Date:  2011-06-04       Impact factor: 3.469

8.  Rendu-Osler disease: treatment with oestrogen/progestagen versus octreotide.

Authors:  Séverin Jeanneret; Loic Regazzoni; Bernard Favrat
Journal:  BMJ Case Rep       Date:  2011-02-23

9.  Spectrum of biliary abnormalities in hepatic hereditary hemorrhagic telangiectasia: demonstration by multidetector computed tomography.

Authors:  Eugene Lin; Luke Stall
Journal:  Emerg Radiol       Date:  2007-04-24

10.  Hereditary hemorrhagic telangiectasia in Japanese patients.

Authors:  Masaki Komiyama; Tomoya Ishiguro; Osamu Yamada; Hiroko Morisaki; Takayuki Morisaki
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.